DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PD

Clinical trial NCT05579379 · UNKNOWN

Trial details

NCT number: NCT05579379
Sponsor: University Hospital Tuebingen
Status: UNKNOWN
Study type: OBSERVATIONAL

Parkinson Disease

Start date: 2022-10-01
Primary completion: 2024-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.